GoodRx Holdings, Inc.
General ticker "GDRX" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $1.7B (TTM average)
GoodRx Holdings, Inc. does not follow the US Stock Market performance with the rate: -6.1%.
Estimated limits based on current volatility of 1.7%: low 2.71$, high 2.80$
Factors to consider:
- Total employees count: 738 (+6.3%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Internal control weaknesses, Labor/talent shortage/retention, Strategic risks and growth management, Customer retention, Market education
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.80$, 6.20$]
- 2025-12-31 to 2026-12-31 estimated range: [2.73$, 6.00$]
Financial Metrics affecting the GDRX estimates:
- Positive: with PPE of 13.7 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 8.31
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: 0.79 < Interest expense per share per price, % of 3.04
- Positive: 41.86 < Shareholder equity ratio, % of 52.21 <= 63.39
- Negative: Inventory ratio change, % of 0.94 > 0.84
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 6.82 < Operating cash flow per share per price, % of 10.57
Short-term GDRX quotes
Long-term GDRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $766.55MM | $750.26MM | $792.32MM |
| Operating Expenses | $764.82MM | $777.27MM | $726.48MM |
| Operating Income | $1.74MM | $-27.01MM | $65.85MM |
| Non-Operating Income | $-24.97MM | $-28.57MM | $-34.39MM |
| Interest Expense | $34.24MM | $56.73MM | $52.92MM |
| R&D Expense | $143.14MM | $135.84MM | $123.75MM |
| Income(Loss) | $-23.23MM | $-55.57MM | $31.46MM |
| Taxes | $9.60MM | $-46.70MM | $15.07MM |
| Profit(Loss)* | $-32.83MM | $-8.87MM | $16.39MM |
| Stockholders Equity | $814.83MM | $761.96MM | $724.66MM |
| Assets | $1,604.63MM | $1,588.80MM | $1,388.07MM |
| Operating Cash Flow | $146.78MM | $138.29MM | $183.89MM |
| Capital expenditure | $55.21MM | $55.77MM | $70.35MM |
| Investing Cash Flow | $-210.50MM | $-55.77MM | $-70.35MM |
| Financing Cash Flow | $-120.23MM | $-167.40MM | $-337.50MM |
| Earnings Per Share** | $-0.08 | $-0.02 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.